Arterial Filter Market Size & Trends
The global arterial filter market size was estimated at USD 616.4 million in 2024 and is projected to grow at a CAGR of 6.0% from 2025 to 2030. This market growth can be attributed to the rising incidence of Cardiovascular Diseases (CVDs) worldwide, increasing demand for cardiac surgeries, and advancements in cardiopulmonary bypass technologies.
Key Highlights
- The North American arterial filter market led the global industry with the largest share of 40.52% in 2024.
- The arterial filter market in the U.S. held the highest share of the North American market in 2024.
- Based on age category, the adult segment led the market with a 78.61% share in 2024.
- Based on end-use, the hospitals segment dominated the market with a share of 40.95% in 2024.
In addition, the growing geriatric population, which is more susceptible to heart conditions, and improved access to healthcare in emerging economies fuel the need for safer and more efficient surgical interventions, boosting the demand for the arterial filter industry. One of the primary market drivers is the rising global burden of CVDs. For instance, in October 2024, the European Journal of Preventive Cardiology highlighted that CVDs are the primary cause of death and illness around the world. Modifiable lifestyle factors, such as poor diet, lack of exercise, smoking, and aging, mostly drive them. Since 1990, the number of people with heart disease has almost doubled, raising the healthcare burden and increasing medical costs. In 2019, well over 500 million people had heart disease. That year, Europe and the U.S. spent over 280 billion euros and USD 400 billion on the disease.
Experts say that by 2050, the U.S. alone might spend around USD 1,344 billion each year on heart disease. This statistic emphasizes the need for urgent preventive policies. Arterial filters are an essential component of these surgeries, as they help prevent the introduction of an embolus (air bubbles, clots, or tissue debris) into the bloodstream during cardiopulmonary bypass, improving patient safety and surgical outcomes. The growing incidence of heart conditions drives an increasing number of surgical procedures, which directly contributes to market expansion.
Expected to drive further market growth is the rapidly growing global geriatric population, which is more vulnerable to CVDs and often requires surgical interventions. As people age, the likelihood of developing conditions such as Coronary Artery Disease (CAD), valvular heart disease, and arrhythmias increases significantly. Our World in Data estimates that there will be approximately 830 million people 65 and older worldwide in November 2024. According to the latest United Nations data, this number is expected to grow to 1.7 billion by 2054. Hence, the geriatric population will more than double in the following decades. We expect a significant shift in Asia, the continent with the largest population.
The number of older people in Asia is also expected to more than double by 2050. This change in population has resulted in a greater need for heart surgeries such as Coronary Artery Bypass Grafting (CABG), valve replacements, and operations that use arterial filters to keep patients safe from blood clots during heart-lung machine procedures. Thus, the growing geriatric population directly contributes to the increasing usage of arterial filters in surgical settings, expanding the arterial filter industry.
Report Coverage & Deliverables
The PDF report and online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Market Concentration & Characteristics
The arterial filter industry exhibits a moderate degree of innovation, driven by continuous advancements in materials, filtration efficiency, and biocompatibility. Manufacturers are integrating cutting-edge membrane technologies and ergonomic designs to enhance blood flow management during cardiovascular surgeries. Emphasis on minimizing embolic events and improving patient outcomes encourages the development of smarter, more precise filters. In addition, innovation is supported by rising investments in R&D and regulatory support for medical device advancements.
Mergers and acquisitions (M&A) in the arterial filter industry remain moderate, largely driven by strategic consolidation among key players in the broader cardiopulmonary and cardiovascular device sectors. While the arterial filter segment is highly specialized, companies increasingly seek to integrate it within comprehensive product portfolios through targeted acquisitions. Notable trends include large medical device firms acquiring niche filter manufacturers to gain a technological edge, expanding surgical product lines, and enhancing global distribution capabilities.
The impact of regulations is considerably high in the arterial filter industry. Strict regulatory approvals from authorities such as the FDA and European Medicines Agency (EMA) ensure high safety, efficacy, and biocompatibility standards. The thorough testing and ongoing monitoring required after a product is on the market have raised costs and lengthened the time it takes to get new filter technologies approved, especially those using new materials or advanced features. However, these regulations have also improved patient safety and clinical outcomes, reinforcing market trust.
Product expansion in the arterial filter industry has been steadily advancing, driven by technological innovation and the growing demand for safer, more efficient cardiopulmonary bypass procedures. Manufacturers are now creating new types of arterial filters that better remove tiny blood clots, have built-in air removal features, and are more compatible with blood. Recent expansions have included pediatric arterial filters, addressing a previously underserved segment.
The arterial filter industry is growing significantly in regions like Asia Pacific, Latin America, and the Middle East, mainly because of better heart care facilities and more advanced surgeries, leading to higher demand than in the usual leading markets like North America and Europe.
Age Category Insights
The adult segment led the market with a 78.61% share in 2024, driven by factors such as the high prevalence of CVDs among adults, an increasing rate of lifestyle-related disorders like hypertension, obesity, and diabetes, and the growing volume of adult open-heart surgeries globally. Adults are more likely to have CAD, aortic valve problems, and heart attacks, which often need cardiopulmonary bypass surgeries where arterial filters are important for getting rid of tiny clots and keeping blood flow safe. As per the U.S. Centers for Disease Control and Prevention, in October 2024, around 1 in 20 adults aged 20 and older had CAD in 2022. This demographic shift and expansion in surgical infrastructure in emerging economies drive the dominance of the adult segment in the market.
The neonatal/pediatric segment is expected to grow at a rate of 5.00% each year during the forecast period, mainly because more babies are being born with Congenital Heart Defects (CHDs), improvements in heart care for children, and more specialized equipment for surgeries on infants and kids. For instance, in March 2025, the U.S. CDC stated that nearly 1% of births in the U.S., or about 40,000 babies, have heart defects each year. Almost 1 in 4 babies with a heart defect has a critical one.
End-use Insights
The hospitals segment dominated the market with a 40.95% share, owing to factors such as the high number of Cardiopulmonary Bypass (CPB) procedures performed in hospital settings, the availability of advanced surgical infrastructure, and a growing focus on patient safety during open-heart surgeries. In addition, hospitals also have the advantages of offering complete care after surgery and using advanced medical devices, which help enhance recovery and make surgeries more successful. Hospitals buy medical devices in bulk, attend to a high volume of patients, and often receive better financial support through insurance and reimbursements.
The Ambulatory Surgical Centers (ASCs) segment is expected to grow at a rate of 6.6% each year during the forecast period, fueled by more people choosing less invasive heart surgeries, the increasing affordability of outpatient surgical care, and the need for quicker patient recovery times. ASCs are gaining popularity due to their lower operational expenses, shorter hospital stays, and improved scheduling flexibility compared to traditional hospitals. These centers are now more often able to carry out some heart procedures that might use short-term extracorporeal support, which involves small arterial filters to keep things safe during the process.
Regional Insights
The North American arterial filter market held the largest share of 40.52% of the global industry. It is driven by expanding cardiac care infrastructure, rising healthcare investment, public sector initiatives to improve surgical outcomes, and ongoing technology reinvestment. Many hospitals are quickly using new filters because they follow the best practices for extracorporeal circulation and have good relationships with device makers. Also, focusing on doing procedures efficiently and keeping patients safe pushes hospitals to use advanced arterial filtration consistently in adult and children's bypass programs.
U.S. Arterial Filter Market Trends
The arterial filter market in the U.S. held the highest share of the North American market in 2024. The country has the highest global volume of cardiac bypass surgeries, supportive Centers for Medicare & Medicaid Services (CMS) reimbursement policies, and a dynamic ecosystem of medical device R&D. Stringent FDA requirements for device safety and efficacy drive manufacturers to continuously improve filter materials and designs. In addition, expanding ambulatory surgical centers performing select cardiac procedures are driving the demand for compact, high-performance arterial filters tailored to outpatient settings.
Europe Arterial Filter Market Trends
The arterial filter market in Europe is expected to grow significantly, fueled by rising investments by public healthcare systems in modernizing cardiac surgery suites and a large geriatric population requiring surgical treatments. The region’s focus on cost-effectiveness and centralized tendering processes also compels suppliers to offer filters combining high performance with competitive pricing.
The UK arterial filter market is driven by a large geriatric population with a high burden of CVDs, extensive public healthcare funding for cardiac surgery, and harmonized regulatory standards under the EU Medical Device Regulation. In addition, Europe's emphasis on value-based healthcare encourages hospitals to standardize high-efficiency arterial filters with low priming volumes and proven biocompatibility, driving the market.
The arterial filter market in Germany is expected to grow at the fastest CAGR over the forecast period, driven by the growing geriatric population, a strong prevalence of CVDs, and the highest per capita rate of cardiac surgeries. The country’s decentralized hospital financing model and Diagnosis-Related Group reimbursement framework allow hospitals to invest in advanced perfusion technologies. At the same time, early health-technology assessment pathways facilitate rapid adoption of innovative devices.
Asia Pacific Arterial Filter Market Trends
The arterial filter market in Asia Pacific is expected to grow at the fastest CAGR of 6.7%, driven by rising CVD prevalence, expanding tertiary care infrastructure, and increasing healthcare spending across emerging economies. Governments prioritize cardiac surgery capacity through public-private partnerships and insurance reforms. The growing middle-class patient population and improving access to advanced surgical tools support strong adoption of arterial filters designed for varied clinical settings.
The China arterial filter market is driven by the large-scale expansion of healthcare infrastructure and strong government initiatives to improve cardiac care across urban and rural regions. Growing cardiovascular health awareness, with strategic public funding for hospitals and specialty cardiac centers, is creating sustained demand for reliable perfusion consumables, further driving the arterial market in the country.
Over the forecast period, we expect the arterial filter market in Japan to grow significantly. The high elderly population, the rise in demand for cardiac interventions, and the country’s comprehensive public health insurance system aid growth. A well-developed medical device sector and supportive regulatory framework enable rapid adoption of new filtration technologies. Emphasis on patient safety and procedural efficiency drives manufacturers to develop compact filters that are easy to integrate into existing perfusion setups and are designed with features that align with the country’s focus on innovation and quality of care.
Latin America Arterial Filter Market Trends
The arterial filter market in Latin America is driven by rapidly growing surgical capacity as countries expand tertiary hospitals and specialized heart centers to address rising CVD burdens. Public–private partnerships are helping this growth by teaming up to provide new hospitals with modern Cardiopulmonary Bypass (CPB) suites that use the latest arterial filtration technology.
Middle East and Africa Arterial Filter Market Trends
The arterial filter market in the Middle East and Africa is growing due to the rising prevalence of CVDs, the growing number of cardiac surgeries, and expanding healthcare infrastructure. In addition, improved access to healthcare, government health initiatives, medical tourism, a high incidence of CHDs, the region's reliance on imports, and the emerging local manufacturing efforts drive the market further.
Key Arterial Filter Company Insights
Some of the leading companies in the arterial filter industry are Medtronic, Pall Corporation, Fresenius Medical Care AG, and Terumo Corporation. These companies prioritize new product development, Research & Development (R&D) investments, and strategic M&As to strengthen their market positions.
Key Arterial Filter Companies
The following are the leading companies in the arterial filter market. These companies collectively hold the largest market share and dictate industry trends.
- Medtronic
- Pall Corporation
- Fresenius Medical Care AG
- Terumo Corporation
- NIPRO
- Haemonetics Corporation
- ICU Medical, Inc.
- Braile Biomédica
- LivaNova, Inc.
- EUROSETS
Arterial Filter Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2025 |
USD 651.3 million |
|
Revenue forecast in 2030 |
USD 870.7 million |
|
Growth rate |
CAGR of 6.0% from 2025 to 2030 |
|
Actual data |
2018-2024 |
|
Forecast period |
2025-2030 |
|
Quantitative units |
Revenue in USD million/billion, and CAGR from 2025 to 2030 |
|
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends, and product outlook |
|
Segments covered |
Age category, end-use, region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
|
Country Scope |
U.S.; Canada; UK; Germany; Italy; France; Spain; Denmark; Sweden; Norway; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
|
Key companies profiled |
Medtronic; Pall Corporation; Fresenius Medical Care AG; Terumo Corporation; NIPRO; Haemonetics Corporation; ICU Medical, Inc.; Braile Biomédica; LivaNova, Inc.; EUROSETS |
| Customization scope |
Free report customization (equivalent to up to 8 analysts' working days) with purchase. You can add or alter the scope of the country and segment. |
|
Pricing and purchase options |
Avail yourself of customized purchase options to meet your exact research needs. Explore purchase options |
Global Arterial Filter Market Report Segmentation
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the subsegments from 2018 to 2030. For this study, MIR has segmented the global arterial filter market report based on age category, end-use, and region
-
Age Category Outlook (Revenue, USD Million, 2018-2030)
-
Adult
-
Neonatal/Pediatric
-
-
End Use Outlook (Revenue, USD Million, 2018-2030)
-
Hospitals
-
Ambulatory Surgical Centers
-
Others
-
-
Regional Outlook (Revenue, USD Million, 2018-2030)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa (MEA)
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy